BCM
PHGE icon

BlueCrest Capital Management’s BiomX PHGE Stock Holding History

BlueCrest Capital Management’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-594
Closed -$1.15M – 541
2019
Q3 		$1.15M Buy
+594
New +$1.16M 0.08% 176

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

BlueCrest Capital Management's PHGE Position: Q4 2019 in Review

BlueCrest Capital Management sold out of BiomX (PHGE) in Q4 2019, closing a stake of 594 shares — an estimated $1.15M sold.

BlueCrest Capital Management first reported a position in PHGE in Q3 2019 and held it in 1 quarter. The position peaked at $1.15M in Q3 2019. 7 funds tracked by Wall St. Rank hold PHGE as of Q4 2019.

  • BlueCrest Capital Management reported no remaining BiomX position as of Q4 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 594 BiomX shares in Q4 2019, an estimated $1.15M.
  • BlueCrest Capital Management first reported a position in BiomX in Q3 2019 and held it in 1 quarter.
  • BlueCrest Capital Management's BiomX position peaked at $1.15M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held BiomX as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.